Skip to menu Skip to content Skip to footer
Professor Glenn King
Professor

Glenn King

Email: 
Phone: 
+61 7 334 62025

Overview

Availability

Professor Glenn King is:
Available for supervision
Media expert

Qualifications

  • Bachelor of Science, University of Sydney
  • Doctor of Philosophy, University of Sydney

Research interests

  • Bugs and drugs

    Our research harnesses the chemistry of venoms from arthropod predators, such as spiders, scorpions and centipedes, to develop novel pharmaceuticals to treat chronic pain, epilepsy and stroke. Stroke is the second-leading cause of death worldwide. In addition, it causes an extremely high incidence of disability in surviving victims due to the brain damage suffered during stroke. Likewise, chronic pain is a huge medical problem that affects one in five adults. There are few drugs available for treating chronic pain, and many of these have limited efficacy and dose-limiting side effects. Animal venoms are a rich source of stable natural peptides that potently modulate the activity of a wide range of neuronal ion channels and receptors. We have the largest collection of arthropod venoms in the world, a high-throughput pipeline for venoms-based drug discovery, protocols for rapid protein expression and structure determination, and links to key laboratories for testing the efficacy of lead molecules in rodent models of pain, epilepsy and stroke. We are using these world-class resources to move us closer to achieving our aim of developing novel analgesics for pain relief, novel drugs for treating severe paediatric epilepsies, and novel neuroprotective agents for treating stroke victims. An equally important focus of our research is on helping to safeguard Australia’s agricultural crops and reduce the spread of disease from insect pests by discovering new environmentally friendly insecticides. Currently, arthropod pests destroy approximately 15 per cent of the world’s food supply and spread pernicious diseases such as dengue and malaria. Our work is finding better, safer ways to control disease-spreading pests and protect crops.

Works

Search Professor Glenn King’s works on UQ eSpace

443 works between 1983 and 2025

141 - 160 of 443 works

2018

Journal Article

Giant fish-killing water bug reveals ancient and dynamic venom evolution in Heteroptera

Walker, Andrew A., Hernández-Vargas, Maria José, Corzo, Gerardo, Fry, Bryan G. and King, Glenn F. (2018). Giant fish-killing water bug reveals ancient and dynamic venom evolution in Heteroptera. Cellular and Molecular Life Sciences, 75 (17), 1-15. doi: 10.1007/s00018-018-2768-1

Giant fish-killing water bug reveals ancient and dynamic venom evolution in Heteroptera

2018

Journal Article

Inhibition of acid-sensing ion channels by diminazene and APETx2 evoke partial and highly variable antihyperalgesia in a rat model of inflammatory pain

Lee, Jia Yu Peppermint, Saez, Natalie J., Cristofori-Armstrong, Ben, Anangi, Raveendra, King, Glenn F., Smith, Maree T. and Rash, Lachlan D. (2018). Inhibition of acid-sensing ion channels by diminazene and APETx2 evoke partial and highly variable antihyperalgesia in a rat model of inflammatory pain. British Journal of Pharmacology, 175 (12), 2204-2218. doi: 10.1111/bph.14089

Inhibition of acid-sensing ion channels by diminazene and APETx2 evoke partial and highly variable antihyperalgesia in a rat model of inflammatory pain

2018

Conference Publication

The use of peptide-membrane interactions in the design of selective and potent sodium channel inhibitors

Schroeder, Christina, Agwa, Akello, Mueller, Alexander, Chow, Chun Yuen, Peigneur, Steve, Lawrence, Nicole, Deplazes, Evelyne, Mark, Alan, Craik, David, Tytgat, Jan, King, Glenn, Vetter, Irina and Henriques, Sonia Troeira (2018). The use of peptide-membrane interactions in the design of selective and potent sodium channel inhibitors. 35th European Peptide Symposium, Dublin City University, Ireland, 26-31 August 2018. Oxford, United Kingdom: John Wiley & Sons.

The use of peptide-membrane interactions in the design of selective and potent sodium channel inhibitors

2018

Conference Publication

Margatoxin-conjugated quantum dots as a tool for targeted inhibition of the voltage-gated potassium channel Kv1.3 in the olfactory bulb

Schwartz, Austin B., Kapur, Anshika, Huang, Zhenbo, Anangi, Raveendra, Deklan, Zoltan, Fardone, Erminia, Palui, Goutam, King, Glenn F., Mattoussi, Hedi and Fadool, Debra A. (2018). Margatoxin-conjugated quantum dots as a tool for targeted inhibition of the voltage-gated potassium channel Kv1.3 in the olfactory bulb. 39th Annual Meeting of the Association for Chemoreception Sciences (AChemS), Bonita Springs, FL, United States, 26-29 April 2017. Oxford, United Kingdom: Oxford University Press .

Margatoxin-conjugated quantum dots as a tool for targeted inhibition of the voltage-gated potassium channel Kv1.3 in the olfactory bulb

2018

Conference Publication

Counter screen of spider venoms reveals novel sodium and calcium channel inhibitors of chronic pain targets.

Cardoso, F. C., Herzig, V., King, G. F. and Lewis, R. J. (2018). Counter screen of spider venoms reveals novel sodium and calcium channel inhibitors of chronic pain targets.. Gordon Research Conference on Venom Evolution, Function and Biomedical Applications 2018, Mount Snow, VT, United States, 5-10 August 2018.

Counter screen of spider venoms reveals novel sodium and calcium channel inhibitors of chronic pain targets.

2018

Conference Publication

Development and application of a peptide inhibitor-bound quantum dot targeting the voltage-gated potassium channel Kv1.3 in the olfactory bulb

Schwartz, Austin B., Kapur, Anshika, Huang, Zhenbo, Anangi, Raveendra, Dekan, Zoltan, Fardone, Erminia, Palui, Goutam, King, Glenn F., Mattoussi, Hedi and Fadool, Debra A. (2018). Development and application of a peptide inhibitor-bound quantum dot targeting the voltage-gated potassium channel Kv1.3 in the olfactory bulb. 62nd Annual Meeting of the Biophysical Society, San Francisco, CA, United States, 17-21 February 2018. St. Louis, MO, United States : Cell Press. doi: 10.1016/j.bpj.2017.11.1753

Development and application of a peptide inhibitor-bound quantum dot targeting the voltage-gated potassium channel Kv1.3 in the olfactory bulb

2018

Conference Publication

Bug off pain: probing P2X channels with venoms

Bibic, L., Herzig, V., King, G. F., Ma, L., Chow, C. Y. and Stokes, L. (2018). Bug off pain: probing P2X channels with venoms. Purines 2018 Basic and Translational Science on Purinergic Signaling and its Components for a Healthy and Better World, Foz do Iguaçu, Brazil, 19-22 June 2018. Dordrecht, Netherlands: Springer.

Bug off pain: probing P2X channels with venoms

2017

Journal Article

The North American Society of Toxinology establishes formal affiliation with Toxicon

Keyler, Daniel E. and King, Glenn F. (2017). The North American Society of Toxinology establishes formal affiliation with Toxicon. Toxicon, 142, A1-A1. doi: 10.1016/j.toxicon.2017.11.009

The North American Society of Toxinology establishes formal affiliation with Toxicon

2017

Journal Article

ArachnoServer 3.0: an online resource for automated discovery, analysis and annotation of spider toxins

Pineda, Sandy S., Chaumeil, Pierre-Alain, Kunert, Anne, Kaas, Quentin, Thang, Mike W. C., Le, Lien, Nuhn, Michael, Herzig, Volker, Saez, Natalie J., Cristofori-Armstrong, Ben, Anangi, Raveendra, Senff, Sebastian, Gorse, Dominique and King, Glenn F. (2017). ArachnoServer 3.0: an online resource for automated discovery, analysis and annotation of spider toxins. Bioinformatics, 34 (6), 1074-1076. doi: 10.1093/bioinformatics/btx661

ArachnoServer 3.0: an online resource for automated discovery, analysis and annotation of spider toxins

2017

Journal Article

Discovery and mode of action of a novel analgesic β-toxin from the African spider Ceratogyrus darlingi

Sousa, Silmara R., Wingerd, Joshua S., Brust, Andreas, Bladen, Christopher, Ragnarsson, Lotten, Herzig, Volker, Deuis, Jennifer R., Dutertre, Sebastien, Vetter, Irina, Zamponi, Gerald W., King, Glenn F., Alewood, Paul F. and Lewis, Richard J. (2017). Discovery and mode of action of a novel analgesic β-toxin from the African spider Ceratogyrus darlingi. PLoS One, 12 (9) e0182848, e0182848. doi: 10.1371/journal.pone.0182848

Discovery and mode of action of a novel analgesic β-toxin from the African spider Ceratogyrus darlingi

2017

Journal Article

Revisiting venom of the sea anemone Stichodactyla haddoni: omics techniques reveal the complete toxin arsenal of a well-studied sea anemone genus

Madio, Bruno, Undheim, Eivind A. B. and King, Glenn F. (2017). Revisiting venom of the sea anemone Stichodactyla haddoni: omics techniques reveal the complete toxin arsenal of a well-studied sea anemone genus. Journal of Proteomics, 166, 83-92. doi: 10.1016/j.jprot.2017.07.007

Revisiting venom of the sea anemone Stichodactyla haddoni: omics techniques reveal the complete toxin arsenal of a well-studied sea anemone genus

2017

Journal Article

Improved efficacy of an arthropod toxin expressing fungus against insecticide-resistant malaria-vector mosquitoes

Bilgo, Etienne, Lovett, Brian, Fang, Weiguo, Bende, Niraj, King, Glenn F., Diabate, Abdoulaye and St Leger, Raymond J. (2017). Improved efficacy of an arthropod toxin expressing fungus against insecticide-resistant malaria-vector mosquitoes. Scientific Reports, 7 (1) 3433, 3433. doi: 10.1038/s41598-017-03399-0

Improved efficacy of an arthropod toxin expressing fungus against insecticide-resistant malaria-vector mosquitoes

2017

Journal Article

Corrigendum: Pharmacological characterisation of the highly Na v 1.7 selective spider venom peptide Pn3a (Scientific Reports (2017) 7 (40883)

Deuis, Jennifer R., Dekan, Zoltan, Wingerd, Joshua S., Smith, Jennifer J., Munasinghe, Nehan R., Bhola, Rebecca F., Imlach, Wendy L., Herzig, Volker, Armstrong, David A., Rosengren, K. Johan, Bosmans, Frank, Waxman, Stephen G., Dib-Hajj, Sulayman D., Escoubas, Pierre, Minett, Michael S., Christie, Macdonald J., King, Glenn F., Alewood, Paul F., Lewis, Richard J., Wood, John N. and Vetter, Irina (2017). Corrigendum: Pharmacological characterisation of the highly Na v 1.7 selective spider venom peptide Pn3a (Scientific Reports (2017) 7 (40883). Scientific Reports, 7 (1) 46816, 46816. doi: 10.1038/srep46816

Corrigendum: Pharmacological characterisation of the highly Na v 1.7 selective spider venom peptide Pn3a (Scientific Reports (2017) 7 (40883)

2017

Journal Article

Modulatory features of the novel spider toxin μ-TRTX-Df1a isolated from the venom of the spider Davus fasciatus

Cardoso, Fernanda Caldas, Dekan, Zoltan, Smith, Jennifer J., Deuis, Jennifer R., Vetter, Irina, Herzig, Volker, Alewood, Paul F., King, Glenn F and Lewis, Richard J. (2017). Modulatory features of the novel spider toxin μ-TRTX-Df1a isolated from the venom of the spider Davus fasciatus. British Journal of Pharmacology, 174 (15), 2528-2544. doi: 10.1111/bph.13865

Modulatory features of the novel spider toxin μ-TRTX-Df1a isolated from the venom of the spider Davus fasciatus

2017

Journal Article

Insect-active toxins with promiscuous pharmacology from the African theraphosid spider Monocentropus balfouri

Smith, Jennifer J., Herzig, Volker, Ikonomopoulou, Maria P., Dziemborowicz, Slawomir, Bosmans, Frank, Nicholson, Graham M. and King, Glenn F. (2017). Insect-active toxins with promiscuous pharmacology from the African theraphosid spider Monocentropus balfouri. Toxins, 9 (5) 155, 155. doi: 10.3390/toxins9050155

Insect-active toxins with promiscuous pharmacology from the African theraphosid spider Monocentropus balfouri

2017

Journal Article

Melt with this kiss: paralyzing and liquefying venom of the assassin bug Pristhesancus plagipennis (Hemiptera: Reduviidae)

Walker, Andrew A. , Madio, Bruno, Jin, Jiayi, Undheim, Eivind A. B. , Fry, Bryan G. and King, Glenn F. (2017). Melt with this kiss: paralyzing and liquefying venom of the assassin bug Pristhesancus plagipennis (Hemiptera: Reduviidae). Molecular and Cellular Proteomics, 16 (4), 552-566. doi: 10.1074/mcp.M116.063321

Melt with this kiss: paralyzing and liquefying venom of the assassin bug Pristhesancus plagipennis (Hemiptera: Reduviidae)

2017

Journal Article

Venom profiling of a population of the theraphosid spider Phlogius crassipes reveals continuous ontogenetic changes from juveniles through adulthood

Santana, Renan C., Perez, David, Dobson, James, Panagides, Nadya, Raven, Robert J., Nouwens, Amanda, Jones, Alun, King, Glenn F. and Fry, Bryan G. (2017). Venom profiling of a population of the theraphosid spider Phlogius crassipes reveals continuous ontogenetic changes from juveniles through adulthood. Toxins, 9 (4) 116, 116. doi: 10.3390/toxins9040116

Venom profiling of a population of the theraphosid spider Phlogius crassipes reveals continuous ontogenetic changes from juveniles through adulthood

2017

Journal Article

The structure, dynamics and selectivity profile of a NaV 1.7 potency-optimised huwentoxin-IV variant

Rahnama, Sassan, Deuis, Jennifer R., Cardoso, Fernanda C., Ramanujam, Venkatraman, Lewis, Richard J., Rash, Lachlan D., King, Glenn F., Vetter, Irina and Mobli, Mehdi (2017). The structure, dynamics and selectivity profile of a NaV 1.7 potency-optimised huwentoxin-IV variant. PLoS One, 12 (3) e0173551, e0173551. doi: 10.1371/journal.pone.0173551

The structure, dynamics and selectivity profile of a NaV 1.7 potency-optimised huwentoxin-IV variant

2017

Journal Article

Potent neuroprotection after stroke afforded by a double-knot spider-venom peptide that inhibits acid-sensing ion channel 1a

Chassagnon, Irene R., McCarthy, Claudia A., Chin, Yanni K.-Y., Pineda, Sandy S., Keramidas, Angelo, Mobli, Mehdi, Pham, Vi, De Silva, T. Michael, Lynch, Joseph W., Widdop, Robert E., Rash, Lachlan D. and King, Glenn F. (2017). Potent neuroprotection after stroke afforded by a double-knot spider-venom peptide that inhibits acid-sensing ion channel 1a. Proceedings from the National Academy of Sciences of the United States of America, 114 (14), 3750-3755. doi: 10.1073/pnas.1614728114

Potent neuroprotection after stroke afforded by a double-knot spider-venom peptide that inhibits acid-sensing ion channel 1a

2017

Journal Article

Insecticidal activity of a recombinant knottin peptide from Loxosceles intermedia venom and recognition of these peptides as a conserved family in the genus

Matsubara, F. H., Meissner, G. O., Herzig, V., Justa, H. C., Dias, B. C. L., Trevisan-Silva, D., Gremski, L. H., Gremski, W., Senff-Ribeiro, A., Chaim, O. M., King, G. F. and Veiga, S. S. (2017). Insecticidal activity of a recombinant knottin peptide from Loxosceles intermedia venom and recognition of these peptides as a conserved family in the genus. Insect Molecular Biology, 26 (1), 25-34. doi: 10.1111/imb.12268

Insecticidal activity of a recombinant knottin peptide from Loxosceles intermedia venom and recognition of these peptides as a conserved family in the genus

Funding

Current funding

  • 2025 - 2029
    Venoms to drugs: translating venom peptides into human therapeutics
    NHMRC Investigator Grants
    Open grant
  • 2024 - 2028
    Spider venom peptides: precision therapy for genetic epilepsies
    NHMRC MRFF Stem Cells Therapies Mission
    Open grant
  • 2024 - 2028
    The HEART REHAB Clinical Trials: Therapeutics to Protect the Human Heart
    MRFF Frontier Health and Medical Research Program administered by AusIndustry
    Open grant
  • 2024 - 2027
    Glycaemic variability: A culprit cause of heart disease in diabetes
    MRFF Targeted Translation Research Accelerator
    Open grant
  • 2023 - 2026
    Therapies for pain relief
    Golden Casket Lottery Corporation Ltd
    Open grant
  • 2023 - 2026
    Peptide Inhibitors Targeting Sodium Channels to Treat Amyotrophic Lateral Sclerosis
    United States Congressionally Directed Medical Research Programs - Amyotrophic Lateral Sclerosis Research Program
    Open grant
  • 2021 - 2028
    ARC Centre of Excellence for Innovations in Peptide and Protein Science
    ARC Centres of Excellence
    Open grant

Past funding

  • 2023 - 2025
    Studying the basis of and developing new therapies to treat heart disease
    IPF Healthy - Medical Research
    Open grant
  • 2022
    Australian Peptide Display Facility (ARC LIEF administered by University of Sydney)
    University of Sydney
    Open grant
  • 2022 - 2024
    Developing a first-in-class therapeutic for chronic visceral pain using venom derived peptides (NHMRC Development Grant administered by SAHMRI)
    South Australian Health and Medical Research Institute Limited
    Open grant
  • 2021 - 2023
    Donation for stroke research
    Golden Casket Lottery Corporation Ltd
    Open grant
  • 2021 - 2025
    Development of drugs to prevent ischemic injuries of the heart and brain
    NHMRC MRFF - Cardiovascular Health Mission
    Open grant
  • 2021 - 2024
    ASIC1a, a new therapeutic drug target for cardiac ischemia
    NHMRC IDEAS Grants
    Open grant
  • 2021 - 2024
    Development of a first-in-class therapeutic for protecting the ischemic heart
    NHMRC Development Grant
    Open grant
  • 2020
    Electrophysiology Platform for Ion-channel Characterisation
    ARC Linkage Infrastructure, Equipment and Facilities
    Open grant
  • 2020 - 2023
    A novel platform for large-scale production of a first-in-class biologic drug for stroke
    NHMRC Development Grant
    Open grant
  • 2019 - 2022
    Gain from pain: new tools from venomous animals for exploring pain pathways
    ARC Discovery Projects
    Open grant
  • 2019
    Chemical Purification Network
    UQ Major Equipment and Infrastructure
    Open grant
  • 2019 - 2021
    Development of a first-in-class neuroprotective drug for protecting the brain after stroke
    NHMRC Development Grant
    Open grant
  • 2019
    Imaging Mass Spectrometry at Higher Mass Resolution
    UQ Research Facilities Infrastructure Grants
    Open grant
  • 2019
    In vivo imaging system for tracking inflammation, infection, cancer, pain and bioactive molecules
    UQ Major Equipment and Infrastructure
    Open grant
  • 2019
    Vevo 3100 Imaging System for ultrahigh resolution and frame rate echocardiographic assessment of small animals.
    UQ Major Equipment and Infrastructure
    Open grant
  • 2019 - 2022
    Virtuous cycles: a novel cyclic peptide approach to develop neuroprotective and cardioprotective drugs
    NHMRC Project Grant
    Open grant
  • 2018 - 2019
    Development of dual Nav1.1/1.7 inhibitors for the treatment of IBS-related pain
    UniQuest Pty Ltd
    Open grant
  • 2018
    High-throughput ion channel pharmacology
    UQ Major Equipment and Infrastructure
    Open grant
  • 2018
    Multichannel peptide synthesiser to accelerate UQ's biodiscovery pipeline and peptide drug development programs
    UQ Major Equipment and Infrastructure
    Open grant
  • 2018 - 2023
    Venoms to drugs: translating venom peptides into human therapeutics
    NHMRC Research Fellowship
    Open grant
  • 2017 - 2018
    Evaluation of the stability of Nav1.1 activating peptides for treatment of Dravet Syndrome
    UniQuest Pty Ltd
    Open grant
  • 2017
    Deep Protein Sequencing, Structure and Quantification Facility
    ARC Linkage Infrastructure, Equipment and Facilities
    Open grant
  • 2017 - 2018
    Australian high field EPR facility (ARC LIEF project administered by the Australian National University)
    Australian National University
    Open grant
  • 2016
    4D Mass Spectrometer
    UQ Major Equipment and Infrastructure
    Open grant
  • 2016
    Integrative blood coagulation research core facility
    UQ Major Equipment and Infrastructure
    Open grant
  • 2016
    Novel Pain therapeutics discovery: Probing molecular mechanisms
    NHMRC Equipment Grant
    Open grant
  • 2016
    Patch-clamp electrophysiology platform for drug and insecticide discovery
    UQ Major Equipment and Infrastructure
    Open grant
  • 2016 - 2018
    Unravelling the molecular diversity and evolution of centipede venoms
    ARC Discovery Projects
    Open grant
  • 2016 - 2018
    Voltage-dependent structural changes in voltage-gated sodium channels
    ARC Discovery Projects
    Open grant
  • 2015 - 2017
    A novel therapeutic intervention for Dravet syndrome
    Citizens United for Research in Epilepsy (CURE)
    Open grant
  • 2015 - 2020
    Evaluation of insecticidal spider peptides
    UniQuest Pty Ltd
    Open grant
  • 2015 - 2017
    Tailoring plant protease inhibitors for control of the crop pest Helicoverpa armigera
    Australia-India Strategic Research Fund
    Open grant
  • 2015 - 2019
    Ion channel modulators of pain pathways
    NHMRC Program Grant
    Open grant
  • 2015
    Murine behavioural phenotyping facility
    UQ Major Equipment and Infrastructure
    Open grant
  • 2015
    Protein Analysis Facility
    UQ Major Equipment and Infrastructure
    Open grant
  • 2014 - 2017
    Imaging the world of miniature venomous arthropods
    ARC Linkage Projects
    Open grant
  • 2014 - 2017
    Discovery and characterisation of novel spider-venom peptides targeting the human Nav1.7 channel
    ARC Linkage Projects
    Open grant
  • 2014 - 2017
    Developing subtype-selective blockers of acid-sensing ion channels for treating peripheral pain
    NHMRC Project Grant
    Open grant
  • 2014 - 2016
    Development of selective blockers of acid sensing ion channel 1a for the treatment of stroke
    NHMRC Project Grant
    Open grant
  • 2014 - 2017
    Endosomal sorting of amyloid precursor protein in Alzheimer's disease
    NHMRC Project Grant
    Open grant
  • 2013 - 2016
    Understanding how membrane trafficking controls the levels of Alzheimer's disease causing Aß peptides
    NHMRC Project Grant
    Open grant
  • 2013 - 2018
    Efficacy Profiling Innovation in Novel Pain Therapeutics Discovery
    ARC Linkage Projects
    Open grant
  • 2013 - 2015
    A novel approach for controlling insect vectors of human disease
    ARC Discovery Projects
    Open grant
  • 2013
    High throughput electrophysiology platform
    UQ Major Equipment and Infrastructure
    Open grant
  • 2013 - 2017
    NHMRC Research Fellowship: Venoms to drugs: translating venom peptides into therapeutics
    NHMRC Research Fellowship
    Open grant
  • 2012 - 2013
    High-resolution and high-throughput Nuclear Magnetic Resonance (NMR) Facility (ARC LIEF Grant administered by JCU)
    ARC LIEF Collaborating/Partner Organisation Contributions
    Open grant
  • 2012 - 2013
    Endosomal protein sorting and APP processing in Alzheimer's disease
    NHMRC Project Grant
    Open grant
  • 2012
    High- throughput Fourier Transform Infrared (FTIR) spectrometer.
    UQ Major Equipment and Infrastructure
    Open grant
  • 2012 - 2014
    Rational development of novel analgesics for the treatment of chronic pain
    NHMRC Project Grant
    Open grant
  • 2011 - 2013
    Development of novel analgesics for the treatment of chronic pain
    UQ FirstLink Scheme
    Open grant
  • 2011 - 2014
    Development of environmentally-friendly bioinsecticides for control of Australian crop pests
    ARC Linkage Projects
    Open grant
  • 2011 - 2012
    High-throughput, high resolution protein-peptide sequencing and quantification facility
    ARC Linkage Infrastructure, Equipment and Facilities
    Open grant
  • 2011
    Auto-iTC200 microcalorimeter for high-throughput molecular interaction analyses
    UQ Major Equipment and Infrastructure
    Open grant
  • 2011 - 2013
    Developing inhibitors of an essential histidine kinase in Staphylococcus aureus
    NHMRC Project Grant
    Open grant
  • 2011 - 2013
    Development of potent and selective blockers of acid sensing ion channels for the treatment of pain
    NHMRC Project Grant
    Open grant
  • 2011 - 2014
    Development of potent and specific modulators of the human sodium channel Nav1.7
    ARC Discovery Projects
    Open grant
  • 2011 - 2012
    Discovery of New P2X7 Blockers from Spider Venoms as Potential Analgesics
    Go8 Australia - Germany Joint Research Co-operation Scheme
    Open grant
  • 2011
    Freedom Evo 150 robotic worktable: Automated high throughput and long-time course spectrophotometric multiwell plate assay system
    UQ Major Equipment and Infrastructure
    Open grant
  • 2010 - 2011
    Advanced molecular discovery and characterisation facility
    ARC Linkage Infrastructure, Equipment and Facilities
    Open grant
  • 2010
    Automated liquid handling platform
    UQ Major Equipment and Infrastructure
    Open grant
  • 2010
    Infrared imaging system for quantitative protein analysis
    UQ Major Equipment and Infrastructure
    Open grant
  • 2010 - 2012
    Peptidic spider toxins: a novel paradigm for control of insect pests
    ARC Discovery Projects
    Open grant
  • 2010
    The development of peptides (mini-proteins) as drugs: improved purification capability
    UQ Major Equipment and Infrastructure
    Open grant
  • 2008 - 2011
    Development of environmentally-friendly insecticides for the Australian livestock industry
    ARC Linkage Projects
    Open grant
  • 2008 - 2011
    Development of novel antibacterial compounds from subtilosin A
    NHMRC Project Grant
    Open grant
  • 2008 - 2010
    Dissecting the divisome: development of antibacterial agents that inhibit bacterial cytokinesis
    NHMRC Project Grant
    Open grant
  • 2008 - 2010
    Examining the role ASIC channels in pain through the development of subtype-specific ASIC channel modulators
    NHMRC Project Grant
    Open grant
  • 2008 - 2010
    Inhibition of histidine kinase signal sensing: a novel paradigm for antimicrobial development
    NHMRC Project Grant
    Open grant
  • 2008 - 2010
    Orally active spider toxins: a novel paradigm for control of insect pests
    ARC Discovery Projects
    Open grant
  • 2007
    Infrastructure start-up package for Professor Glenn King
    NHMRC Equipment Grant
    Open grant
  • 2007 - 2009
    Safeguarding Australia against invasive arthropod pests
    ARC Discovery Projects
    Open grant

Supervision

Availability

Professor Glenn King is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Supervision history

Current supervision

  • Doctor Philosophy

    Venom-derived drugs for targeting ion channels involved in genetic epilepsies

    Principal Advisor

    Other advisors: Associate Professor Lata Vadlamudi, Dr Natalie Saez

  • Doctor Philosophy

    Using genetics to predict drug efficacy and on-target side effects of pharmacological agents

    Associate Advisor

    Other advisors: Associate Professor Sonia Shah, Professor David Evans

  • Doctor Philosophy

    Selective modulation voltage gated sodium channels to investigate pathophysiology and treatment for motor neuron disease

    Associate Advisor

    Other advisors: Dr Fernanda Cardoso

  • Doctor Philosophy

    Evaluation of Phylogenetic Patterns of Scorpion Pathophysiological Effects and Effectiveness of Next-Generation Antivenoms

    Associate Advisor

    Other advisors: Dr Sam Robinson, Professor Bryan Fry

  • Master Philosophy

    Towards understanding the venom toxins of Ochrogaster lunifer, a caterpillar of medical and veterinary importance

    Associate Advisor

    Other advisors: Dr Andrew Walker

  • Doctor Philosophy

    Evolution and function of nettle caterpillar venom toxins

    Associate Advisor

    Other advisors: Dr Andrew Walker

  • Doctor Philosophy

    Salivary Adaptations in Australian Blood-feeding Arthropods: Insights from Tabanid Flies and the Australian Paralysis Tick

    Associate Advisor

    Other advisors: Dr Andrew Walker

Completed supervision

Media

Enquiries

Contact Professor Glenn King directly for media enquiries about:

  • Chronic pain
  • Dravet syndrome
  • drug discovery
  • epilepsy
  • Insecticides
  • Ion channel drugs
  • NMR spectroscopy
  • pain drugs
  • painkillers
  • peptide drugs
  • Protein structure
  • Stroke
  • Venomous animals

Need help?

For help with finding experts, story ideas and media enquiries, contact our Media team:

communications@uq.edu.au